Bevantolol

Bevantolol is a selective β-1 adrenoceptor antagonist. Bevantolol can be used for the research of angina pectoris and hypertension[1].

Product Specifications

CAS Number

[59170-23-9]

UNSPSC

12352005

Hazard Statement

H315-H319-H320

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/bevantolol.html

Solubility

10 mM in DMSO

Smiles

OC(COC1=CC=CC(C)=C1)CNCCC2=CC=C(OC)C(OC)=C2

Molecular Formula

C20H27NO4

Molecular Weight

345.43

Precautions

P264-P280-P302+P352-P305+P351+P338-P362

References & Citations

[1]Williams EMV. Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actions. J Clin Pharmacol. 1987 Jul;27 (7) :450-60.|[2]Dukes ID, et, al. Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile. Br J Pharmacol. 1985 Feb;84 (2) :365-80.